je.st
news
AstraZeneca plc (AZN) Price Target Cut to GBX 5,600 by Analysts at Deutsche Bank
2016-03-25 07:39:57| Biotech - Topix.net
The brokerage presently has a "buy" rating on the biopharmaceutical company's stock. Deutsche Bank's price objective suggests a potential upside of 43.33% from the stock's current price.
Tags: price
bank
cut
target
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||